PGNY Q2 2023 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena

PGNYProgyny, Inc.

$1B

Q2 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$279M+43.3% YoY

Gross Profit

$61M21.7% margin

Operating Income

$15M5.4% margin

Net Income

$15M5.4% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

+8.1%

Cash Flow

Operating Cash Flow

$76M

Free Cash Flow

$75M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$682M

Total Liabilities

$212M

Stockholders' Equity

$469M

Cash & Equivalents

$171M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$279M	$195M	+43.3%
Gross Profit	$61M	$44M	+38.2%
Operating Income	$15M	$9M	+71.8%
Net Income	$15M	$9M	+71.0%

Revenue Segments

Fertility benefit services revenue

$173M62%

Pharmacy benefit services revenue

$107M38%